Johnson Investment Counsel’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-62,460
Closed -$180K 671
2021
Q3
$180K Hold
62,460
﹤0.01% 630
2021
Q2
$237K Hold
62,460
﹤0.01% 577
2021
Q1
$211K Hold
62,460
﹤0.01% 579
2020
Q4
$175K Hold
62,460
﹤0.01% 576
2020
Q3
$157K Buy
62,460
+500
+0.8% +$1.26K ﹤0.01% 556
2020
Q2
$841K Buy
+61,960
New +$841K 0.02% 312
2020
Q1
Sell
-76,141
Closed -$481K 532
2019
Q4
$481K Hold
76,141
0.01% 422
2019
Q3
$298K Hold
76,141
0.01% 501
2019
Q2
$368K Hold
76,141
0.01% 476
2019
Q1
$623K Buy
76,141
+14,679
+24% +$120K 0.01% 377
2018
Q4
$339K Hold
61,462
0.01% 460
2018
Q3
$542K Hold
61,462
0.01% 423
2018
Q2
$613K Sell
61,462
-105
-0.2% -$1.05K 0.02% 399
2018
Q1
$586K Buy
61,567
+105
+0.2% +$999 0.02% 388
2017
Q4
$913K Sell
61,462
-1,000
-2% -$14.9K 0.02% 288
2017
Q3
$1.23M Sell
62,462
-859
-1% -$16.9K 0.03% 222
2017
Q2
$909K Sell
63,321
-2,071
-3% -$29.7K 0.03% 268
2017
Q1
$601K Buy
65,392
+2,930
+5% +$26.9K 0.02% 339
2016
Q4
$650K Sell
62,462
-37,303
-37% -$388K 0.02% 307
2016
Q3
$902K Buy
99,765
+2,930
+3% +$26.5K 0.03% 236
2016
Q2
$724K Buy
96,835
+2,930
+3% +$21.9K 0.02% 267
2016
Q1
$846K Buy
93,905
+2,930
+3% +$26.4K 0.03% 239
2015
Q4
$1.18M Sell
90,975
-7,026
-7% -$90.7K 0.04% 197
2015
Q3
$946K Buy
98,001
+22,613
+30% +$218K 0.03% 220
2015
Q2
$775K Buy
+75,388
New +$775K 0.03% 246